T. Rowe Price Associates
AORT icon

T. Rowe Price Associates’s Artivion AORT Stock Holding History

T. Rowe Price Associates’s Portfolio AORT Stock Details AORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.92M Buy
52,343
+9,021
+21% +$356K ﹤0.01% 1839
2025
Q4 		$1.98M Buy
43,322
+3,288
+8% +$146K ﹤0.01% 1755
2025
Q3 		$1.7M Sell
40,034
-3,337
-8% -$126K ﹤0.01% 1805
2025
Q2 		$1.35M Buy
43,371
+2,071
+5% +$56K ﹤0.01% 1836
2025
Q1 		$1.02M Buy
41,300
+1,811
+5% +$50.3K ﹤0.01% 1949
2024
Q4 		$1.13M Buy
39,489
+3,950
+11% +$110K ﹤0.01% 1913
2024
Q3 		$947K Buy
35,539
+459
+1% +$11.9K ﹤0.01% 1992
2024
Q2 		$900K Buy
35,080
+1,390
+4% +$31.2K ﹤0.01% 1943
2024
Q1 		$713K Buy
33,690
+1,634
+5% +$30.4K ﹤0.01% 2059
2023
Q4 		$574K Sell
32,056
-5,432
-14% -$84.5K ﹤0.01% 2117
2023
Q3 		$569K Buy
37,488
+1,024
+3% +$16.6K ﹤0.01% 2042
2023
Q2 		$627K Buy
36,464
+566
+2% +$8.34K ﹤0.01% 2029
2023
Q1 		$471K Buy
35,898
+6,247
+21% +$79.8K ﹤0.01% 2131
2022
Q4 		$359K Sell
29,651
-3,666
-11% -$44K ﹤0.01% 2301
2022
Q3 		$462K Buy
33,317
+2,369
+8% +$47.7K ﹤0.01% 2161
2022
Q2 		$584K Buy
30,948
+306
+1% +$5.9K ﹤0.01% 2159
2022
Q1 		$655K Buy
30,642
+8,794
+40% +$170K ﹤0.01% 2220
2021
Q4 		$445K Sell
21,848
-700
-3% -$14.1K ﹤0.01% 2441
2021
Q3 		$503K Sell
22,548
-110
-0.5% -$2.83K ﹤0.01% 2382
2021
Q2 		$643K Buy
22,658
+688
+3% +$18.8K ﹤0.01% 2269
2021
Q1 		$496K Sell
21,970
-3,432
-14% -$84K ﹤0.01% 2371
2020
Q4 		$600K Sell
25,402
-5,800
-19% -$118K ﹤0.01% 2175
2020
Q3 		$576K Hold
31,202
– – ﹤0.01% 2031
2020
Q2 		$598K Buy
31,202
+116
+0.4% +$2.46K ﹤0.01% 1985
2020
Q1 		$526K Buy
31,086
+235
+0.8% +$6.03K ﹤0.01% 1970
2019
Q4 		$836K Buy
30,851
+1,449
+5% +$35.6K ﹤0.01% 1967
2019
Q3 		$798K Buy
29,402
+126
+0.4% +$3.57K ﹤0.01% 1908
2019
Q2 		$876K Buy
29,276
+3,046
+12% +$90.4K ﹤0.01% 1895
2019
Q1 		$765K Buy
26,230
+9,600
+58% +$274K ﹤0.01% 1956
2018
Q4 		$472K Buy
16,630
+60
+0.4% +$1.8K ﹤0.01% 2100
2018
Q3 		$583K Sell
16,570
-191
-1% -$6.16K ﹤0.01% 2090
2018
Q2 		$467K Buy
16,761
+62
+0.4% +$1.56K ﹤0.01% 2168
2018
Q1 		$335K Buy
16,699
+63
+0.4% +$1.21K ﹤0.01% 2247
2017
Q4 		$319K Buy
16,636
+1,000
+6% +$20K ﹤0.01% 2257
2017
Q3 		$355K Hold
15,636
– – ﹤0.01% 2216
2017
Q2 		$312K Buy
15,636
+1,100
+8% +$19.7K ﹤0.01% 2233
2017
Q1 		$242K Hold
14,536
– – ﹤0.01% 2332
2016
Q4 		$278K Sell
14,536
-14
-0.1% -$255 ﹤0.01% 2274
2016
Q3 		$256K Hold
14,550
– – ﹤0.01% 2273
2016
Q2 		$172K Hold
14,550
– – ﹤0.01% 2358
2016
Q1 		$156K Hold
14,550
– – ﹤0.01% 2342
2015
Q4 		$157K Buy
14,550
+100
+0.7% +$1.05K ﹤0.01% 2351
2015
Q3 		$141K Hold
14,450
– – ﹤0.01% 2362
2015
Q2 		$163K Hold
14,450
– – ﹤0.01% 2390
2015
Q1 		$150K Hold
14,450
– – ﹤0.01% 2419
2014
Q4 		$164K Hold
14,450
– – ﹤0.01% 2398
2014
Q3 		$143K Hold
14,450
– – ﹤0.01% 2414
2014
Q2 		$129K Hold
14,450
– – ﹤0.01% 2440
2014
Q1 		$144K Hold
14,450
– – ﹤0.01% 2384
2013
Q4 		$160K Buy
14,450
+700
+5% +$6.59K ﹤0.01% 2356
2013
Q3 		$96K Hold
13,750
– – ﹤0.01% 2389
2013
Q2 		$86K Buy
+13,750
New +$83.9K ﹤0.01% 2360

Other funds holding AORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

T. Rowe Price Associates's AORT Position: Q1 2026 in Review

T. Rowe Price Associates increased its Artivion (AORT) stake by 21% in Q1 2026, buying an estimated $356K and bringing the position to 52,343 shares worth $1.92M. The position accounts for ﹤0.01% of the portfolio, ranked #1839.

T. Rowe Price Associates first reported a position in AORT in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.98M in Q4 2025. 239 funds tracked by Wall St. Rank hold AORT as of Q1 2026.

  • T. Rowe Price Associates held 52,343 shares of Artivion worth $1.92M as of Q1 2026.
  • T. Rowe Price Associates bought 9,021 Artivion shares in Q1 2026, an estimated $356K.
  • Artivion made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1839 holding.
  • T. Rowe Price Associates first reported a position in Artivion in Q2 2013 and has held it in 52 quarters since.
  • T. Rowe Price Associates's Artivion position peaked at $1.98M in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Artivion as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.